Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923 This issue Cite

Erratum

The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum

Jingfeng Zhou, Bei Jin, Yanli Jin, Yizhi Liu, Jingxuan Pan

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, 54 S. Xianlie Road, Guangzhou, 510060, China

Citation:
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm
Other styles

File import instruction

Corrected-article in Theranostics, Volume 7, 1447


Citation styles

APA
Zhou, J., Jin, B., Jin, Y., Liu, Y., Pan, J. (2020). The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics, 10(16), 7401-7402. https://doi.org/10.7150/thno.47923.

ACS
Zhou, J.; Jin, B.; Jin, Y.; Liu, Y.; Pan, J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020, 10 (16), 7401-7402. DOI: 10.7150/thno.47923.

NLM
Zhou J, Jin B, Jin Y, Liu Y, Pan J. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics 2020; 10(16):7401-7402. doi:10.7150/thno.47923. https://www.thno.org/v10p7401.htm

CSE
Zhou J, Jin B, Jin Y, Liu Y, Pan J. 2020. The antihelminthic drug niclosamide effectively inhibits the malignant phenotypes of uveal melanoma in vitro and in vivo: Erratum. Theranostics. 10(16):7401-7402.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image